Dual Diagnosis Clinical Trial
Official title:
Dual Diagnosis Self-Help Group Referral: Outcomes and Services Use
This project will help counselors in substance abuse treatment programs make effective referrals of dually diagnosed patients (those with a co-occurring psychiatric disorder) to self-help groups.
Background:
Dual diagnosis (psychiatric and substance use) patients' (DDPs) participation in 12-step
mutual-help groups is linked to lower relapse and treatment utilization rates. However, under
usual referral, many DDPs do not attend, or sustain attendance of, substance-focused groups
(SFG). DDPs may benefit from dual-focused groups (DFGs).
Objectives:
(1) Implement and validate procedures to help counselors make effective referrals to DFGs.
DDPs were assigned to a standard- or intensive-referral to DFG condition to determine the
extent to which intensive referral, compared to standard referral, increased patients'
mutual-help group participation. (2) Determine whether DDPs who received intensive referral
had better substance use and psychiatric outcomes.
Methods:
DDPs entering VA outpatient mental health treatment received either standard (N=145) or
intensive (N=142) referral. Standard referral consisted essentially of the counselor
recommending DFG participation. The keys to intensive referral were a DFG orientation and the
counselor facilitating direct contact between the patient and a DFG member, and following up
on recommendations for mutual help. Patients were followed at six months (80%), one year
(81%) and two years (80%) to determine whether intensive referral resulted in more DFG and
SFG participation, and better substance use and psychiatric outcomes.
Status:
Completed.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05054738 -
CRP and S&A for Inpatient Veterans
|
N/A | |
Completed |
NCT02233738 -
Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services
|
N/A | |
Completed |
NCT02192931 -
A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users
|
Phase 4 | |
Completed |
NCT00970372 -
Dual-Diagnosis and Compulsory Treatment
|
N/A | |
Completed |
NCT02520271 -
Ostrobothnia Depression Study (ODS). A Naturalistic Follow-up Study on Depression and Related Substance Use Disorders
|
N/A | |
Completed |
NCT00498550 -
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
|
Phase 4 | |
Not yet recruiting |
NCT06315660 -
VR Based Therapy to Treat Anxiety in Dual Diagnosis
|
N/A | |
Recruiting |
NCT06311838 -
Building Social and Structural Connections for the Prevention of Opioid Use Disorder Among Youth Experiencing Homelessness
|
N/A | |
Completed |
NCT00706901 -
Impact of Group Motivational Interviewing and In-Home-Messaging-Devices for Dually Diagnosed Veterans
|
N/A | |
Terminated |
NCT00169026 -
Alcoholism and Schizophrenia: Effects of Clozapine
|
Phase 4 | |
Completed |
NCT01639872 -
Clozapine for Cannabis Use in Schizophrenia
|
Phase 4 | |
Active, not recruiting |
NCT02404662 -
Trial of Supportive Text Messages for Patients With Alcohol Use Disorder and a Co-morbid Depression
|
N/A | |
Completed |
NCT00218582 -
Effectiveness of Self-Help for Dually-Diagnosed Persons - 1
|
Phase 1/Phase 2 | |
Recruiting |
NCT04105231 -
Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use
|
Phase 2 | |
Completed |
NCT01964404 -
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?
|
Phase 1 | |
Completed |
NCT00105768 -
Effectiveness of Advisor-Teller Money Manager
|
Phase 1/Phase 2 | |
Completed |
NCT01514630 -
Creatine as a Treatment Option for Depression in Methamphetamine Using Females
|
Phase 4 | |
Terminated |
NCT02189915 -
Open-Label Creatine Study for Female Meth Users
|
N/A | |
Completed |
NCT02082678 -
Ondansetron for Bipolar Disorder and Alcohol Use Disorders
|
Phase 4 | |
Completed |
NCT01411085 -
Risperidone and Desipramine in Alcohol Use and Schizophrenia
|
Phase 2 |